This 2011 cohort study followed 5,338 Danish men, including 1,862 classified as obese (BMI ≥31 kg/m²) at a median age of 19, over a 65-year period. The study found that obese men had a twofold higher all-cause mortality risk compared to controls (HR: 2.10; 95% CI: 1.84–2.39). Median survival was
This systematic review, conducted for the U.S. Preventive Services Task Force (USPSTF), evaluated the effectiveness of behavioral counseling interventions aimed at promoting a healthful diet and physical activity among adults without known cardiovascular disease (CVD) risk factors. The analysis included 88 randomized controlled trials encompassing over 121,000 participants. Interventions varied
This meta-analysis highlights the benefits of hormone replacement therapy (HRT) for women aged 50-59, within 10 years of menopause. HRT is shown to reduce coronary heart disease, lower all-cause mortality, and alleviate osteoporosis without significant risks like breast cancer in younger women. It suggests that early-stage HRT may be a
This case-control study investigated the relationship between combined estrogen and progestin hormone replacement therapy (HRT) and breast cancer risk in middle-aged women. The study found no significant increase in breast cancer risk for women using HRT, with a potential reduction in risk for long-term users. These findings suggest that combined
This cohort study from the UK Biobank analyzed the relationship between physical activity and the risk of mortality and cardiovascular disease (CVD) in 130,000 participants. It found that even small amounts of exercise, such as 150 minutes per week, significantly reduced the risk of death from all causes and CVD,
